This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Jan Hörling: Innovator in Medical Research
Introduction
Jan Hörling is a notable inventor based in Lidingö, Sweden. He has made significant contributions to the field of medical research, particularly in relation to obesity and diabetes. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Jan Hörling holds a patent for "Promoter sequences." This invention pertains to an isolated human Site-1 Protease promoter region. The patent also includes screening methods for agents that decrease the expression of Site-1 protease, which may be useful in treating medical conditions related to obesity and diabetes.
Career Highlights
Jan is associated with Biovitrum AB, a company that focuses on biopharmaceuticals. His work at Biovitrum has allowed him to explore and develop groundbreaking solutions in the medical field.
Collaborations
Throughout his career, Jan has collaborated with esteemed colleagues such as Lars Abrahamsén and Per Johansson. These partnerships have enhanced his research and contributed to the advancement of medical innovations.
Conclusion
Jan Hörling's contributions to medical research through his patent and collaborations highlight his role as an innovator in the field. His work continues to pave the way for potential treatments for obesity and diabetes.